BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 17, 2003
View Archived Issues
EPIX Medical Files NDA For Its Blood-Pool Agent MS-325
EPIX Medical Inc. filed its first new drug application along with partner, Schering AG, for a blood-pool agent called MS-325 for vascular imaging with magnetic resonance angiography. (BioWorld Today)
Read More
Pharmos Prices $27M Offering; Brain-Injury Drug In Phase III
Read More
InterMune's Pivotal Phase III For IPF Drug Starts Enrolling
Read More
FDA Receives Supplemental NDA For Fuzeon From Trimeris, Roche
Read More
Clarification
Read More
Other News To Note
Read More